- Filed
- Mar 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 16, 2026 | 16.57M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 8.5M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 7.74M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$177.23M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$191.54M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $58.13M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $190.3M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$132.45M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $44.6M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $149.65M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $75.13M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $131.89M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $306.28M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $342.61M |
| Current Assets | FY 2025 · Dec 31, 2025 | $150.93M |
| Current Assets | FY 2025 · Dec 31, 2024 | $343.31M |
| Total Assets | FY 2025 · Dec 31, 2025 | $173.83M |
| Total Assets | FY 2025 · Dec 31, 2024 | $387.21M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$22.49 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$29.40 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$22.49 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$29.40 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $41.02M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $48.45M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $166.42M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $252.04M |
| Net Income | FY 2025 · Dec 31, 2025 | −$191.09M |
| Net Income | FY 2025 · Dec 31, 2024 | −$227.46M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$158.37M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$238.45M |
| Revenue | FY 2025 · Dec 31, 2025 | $102.48M |
| Revenue | FY 2025 · Dec 31, 2024 | $62.04M |